AgingResearch.NewsJoin free

Xu Han

Works at

Sources: reporter.nih.gov

Grants and prizes

  • NIH Office of the Director

    R44, Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery, R44OD035392, 2024–2027, Aug 18, 2025

  • NIH Office of the Director

    R44, An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues, R44OD020163, 2015–2023, Aug 12, 2020

  • NIH Office of the Director

    R43, In-Situ Cryopreservation Without Cryoprotectants, R43OD026279, 2018–2021, Aug 3, 2018

Sources: reporter.nih.gov